We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10.9B
AUM Growth
+$843M
(+8.4%)
Cap. Flow
+$426M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
1,453
New
18
Increased
663
Reduced
669
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$32.9M |
| 2 |
Microsoft
MSFT
|
+$24.3M |
| 3 |
Amazon
AMZN
|
+$21.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17.4M |
| 5 |
DuPont de Nemours
DD
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$16.3M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$13.1M |
| 3 |
A.O. Smith
AOS
|
+$9.9M |
| 4 |
S&P Global
SPGI
|
+$8.24M |
| 5 |
AbbVie
ABBV
|
+$6.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.75% |
| 2 | Financials | 14.74% |
| 3 | Technology | 14.3% |
| 4 | Consumer Staples | 10.87% |
| 5 | Industrials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHS
1326
DELISTED
Chicos FAS, Inc.
CHS
| $102K | ﹤0.01% |
11,344
-9,561
| -46% | -$81.3K |
|
|
TRVN
1327
DELISTED
Trevena, Inc.
TRVN
| $96K | ﹤0.01% |
60
+4
| +7% | +$6.29K |
|
|
WIN
1328
DELISTED
Windstream Holdings Inc
WIN
| $96K | ﹤0.01% |
10,903
+372
| +4% | +$4.93K |
|
|
OMED
1329
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $96K | ﹤0.01% |
21,195
+1,883
| +10% | +$7.63K |
|
|
GCI
1330
DELISTED
Gannett Co., Inc
GCI
| $94K | ﹤0.01% |
10,437
-2,263
| -18% | -$19.4K |
|
1331
XBiotech
XBIT
$69.5M
| $93K | ﹤0.01% |
21,275
+1,452
| +7% | +$6.86K |
|
1332
Helix Energy Solutions
HLX
$1.43B
| $91K | ﹤0.01% |
12,376
-2,101
| -15% | -$13.3K |
|
|
CYS
1333
DELISTED
CYS Investments Inc.
CYS
| $90K | ﹤0.01% |
10,415
-43,258
| -81% | -$373K |
|
1334
First Bancorp
FBP
$4.4B
| $86K | ﹤0.01% |
16,743
-5,574
| -25% | -$31.8K |
|
|
ARLZ
1335
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $86K | ﹤0.01% |
37,651
+3,853
| +11% | +$5.16K |
|
|
FIT
1336
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $84K | ﹤0.01% |
12,009
-3,427
| -22% | -$19.9K |
|
1337
Community Health Systems
CYH
$392M
| $81K | ﹤0.01% |
10,524
-3,857
| -27% | -$30.1K |
|
|
AVP
1338
DELISTED
Avon Products, Inc.
AVP
| $73K | ﹤0.01% |
31,401
-2,799
| -8% | -$8.3K |
|
|
OTIC
1339
DELISTED
Otonomy, Inc.
OTIC
| $62K | ﹤0.01% |
19,007
+985
| +5% | +$13.3K |
|
1340
TherapeuticsMD
TXMD
$23.8M
| $57K | ﹤0.01% |
215
-61
| -22% | -$17.6K |
|
|
ISEE
1341
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $57K | ﹤0.01% |
20,244
+1,842
| +10% | +$4.97K |
|
|
ARAV
1342
DELISTED
Aravive, Inc. Common Stock
ARAV
| $55K | ﹤0.01% |
3,718
+225
| +6% | +$22.7K |
|
|
FMSA
1343
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $51K | ﹤0.01% |
10,663
-3,045
| -22% | -$9.85K |
|
1344
Scorpio Tankers
STNG
$3.95B
| $50K | ﹤0.01% |
1,458
+1
| +0.1% | +$36 |
|
|
DNR
1345
DELISTED
Denbury Resources, Inc.
DNR
| $47K | ﹤0.01% |
35,190
-10,685
| -23% | -$13.9K |
|
|
KLDX
1346
DELISTED
KLONDEX MINES LTD
KLDX
| $44K | ﹤0.01% |
12,093
-3,451
| -22% | -$11.5K |
|
1347
Plug Power
PLUG
$3.06B
| $40K | ﹤0.01% |
15,362
-4,381
| -22% | -$9.76K |
|
|
ASNA
1348
DELISTED
Ascena Retail Group, Inc.
ASNA
| $39K | ﹤0.01% |
799
-172
| -18% | -$7.46K |
|
1349
TETRA Technologies
TTI
$1.26B
| $29K | ﹤0.01% |
10,131
-1,716
| -14% | -$4.21K |
|
|
AXAS
1350
DELISTED
Abraxas Petroleum Corp
AXAS
| $20K | ﹤0.01% |
521
-148
| -22% | -$5.04K |
|
Similar funds
ProShare Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, ProShare Advisors held 1,453 positions worth $10.9B, up 8.4% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $426M of net new capital in Q3 2017, opening 18 new positions and adding to 663 existing holdings. Its largest new stake was Baker Hughes: 116,604 shares worth $4.27M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was CR Bard Inc., an estimated $13.1M trimmed.
- ProShare Advisors's largest Q3 2017 buy was Baker Hughes: 116,604 shares worth $4.27M.
- ProShare Advisors added most to Apple in Q3 2017, an estimated $32.9M increase.
- ProShare Advisors's biggest Q3 2017 reduction was CR Bard Inc., cutting an estimated $13.1M.
- ProShare Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $16.3M.
- ProShare Advisors's ten largest holdings make up 16% of its $10.9B portfolio in Q3 2017.
- ProShare Advisors opened 18 new positions and closed 101 in Q3 2017.
- ProShare Advisors's portfolio value rose 8.4% quarter-over-quarter to $10.9B.
Based on ProShare Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.